Oncoinvent

Oncoinvent is a drug development company based in Oslo, Norway. Oncoinvent develops novel alpha-emitting radioactive cancer treatments. Oncoinvents lead product Radspherin is currently undergoing clinical testing for the treatment of peritoneal carcinomatosis, a common metastatic complication of colorectal and ovarian cancer.

Year of investment
2020

Sector
Drug development

Location
Oslo, Norway

Website
https://www.oncoinvent.com/